STO 125 Pill — BROWN OVAL, 14mm — Carbidopa Levodopa

STO pill photo
View full Carbidopa Levodopa profile
ImprintSTO / 125
ColourBROWN
ShapeOVAL
Size14
StrengthCARBIDOPA 31.25 mg;LEVODOPA 125 mg;ENTACAPONE 200 mg
Dosage formTablet, Film Coated
ManufacturerMylan Pharmaceuticals Inc.
NDC0378-8303
Schedule—
Availability—
IngredientsCARBIDOPA[CARBIDOPA ANHYDROUS];LEVODOPA[LEVODOPA];ENTACAPONE[ENTACAPONE]

What does this imprint mean?

The imprint "STO 125" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.

Active ingredient

Carbidopa Levodopa

Uses and warnings

No boxed warning. The label warns that patients "have reported suddenly falling asleep without prior warning of sleepiness while engaged in activities of daily living." It also notes "seizures associated with vitamin B6 deficiency have been reported," sporadic cases of a symptom complex "resembling neuroleptic malignant syndrome (NMS)" with dose reduction or withdrawal, and impulse control problems including "intense urge to gamble, increased sexual urges...binge eating."

SINEMET is indicated in the treatment of Parkinson's disease, post-encephalitic parkinsonism, and symptomatic parkinsonism that may follow carbon monoxide intoxication or manganese intoxication.

Read the full drug profile →

How to identify this pill

Similar-looking pills

Other pills of Carbidopa Levodopa

Official references

Source: FDA Structured Product Label via NLM Pillbox archive (retired 2021); source file faf9e791-38ce-41a4-bab9-ee1aa6e4ff2a.xml